Related references
Note: Only part of the references are listed.CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapy
Ayaka Hara et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Effects of doxorubicin on the heart: From molecular mechanisms to intervention strategies
Nanthip Prathumsap et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Melatonin attenuates doxorubicin-induced cardiotoxicity through preservation of YAP expression
Hai-ru Li et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Positive and negative cooperativity of TNF and Interferon-γ in regulating synovial fibroblast function and B cell survival in fibroblast/B cell co-cultures
Torsten Lowin et al.
SCIENTIFIC REPORTS (2020)
Activation of invariant natural killer T cells by alpha-galactosylceramide ameliorates doxorubicin-induced cardiotoxicity in mice
Yoshikuni Obata et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)
A phase I study of loco-regional immunotherapy by transbronchial injection of α-galactosylceramide-pulsed antigen presenting cells in patients with lung cancer
Fumihiro Ishibashi et al.
CLINICAL IMMUNOLOGY (2020)
Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity
Tomonori Tadokoro et al.
JCI INSIGHT (2020)
Follistatin-Like 1 Protects against Doxorubicin-Induced Cardiomyopathy through Upregulation of Nrf2
Yintao Zhao et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Doxorubicin-induced cardiomyopathy associated with inhibition of autophagic degradation process and defects in mitochondrial respiration
Chowdhury S. Abdullah et al.
SCIENTIFIC REPORTS (2019)
A sequential interferon gamma directed chemotactic cellular immune response determines survival and cardiac function post-myocardial infarction
Stefanie Finger et al.
CARDIOVASCULAR RESEARCH (2019)
Imbalance of Ly-6Chi and Ly-60lo Monocytes/Macrophages Worsens Hyperoxia-Induced Lung Injury and Is Rescued by IFN-γ
Laurie C. Eldredge et al.
JOURNAL OF IMMUNOLOGY (2019)
Blockade of L-type Ca2+ channel attenuates doxorubicin-induced cardiomyopathy via suppression of CaMKII-NF-κB pathway
Soichiro Ikeda et al.
SCIENTIFIC REPORTS (2019)
IFN-γ restores the impaired function of RNase L and induces mitochondria-mediated apoptosis in lung cancer
Huijing Yin et al.
CELL DEATH & DISEASE (2019)
Exosome Treatment Enhances Anti-Inflammatory M2 Macrophages and Reduces Inflammation-Induced Pyroptosis in Doxorubicin-Induced Cardiomyopathy
Dinender K. Singla et al.
CELLS (2019)
Doxorubicin-induced cardiotoxicity involves IFNγ-mediated metabolic reprogramming in cardiomyocytes
Chen Ni et al.
JOURNAL OF PATHOLOGY (2019)
Peroxisome Proliferator-Activated Receptor-α Inhibition Protects Against Doxorubicin-Induced Cardiotoxicity in Mice
Mahdieh Rahmatollahi et al.
CARDIOVASCULAR TOXICOLOGY (2016)
Invariant NKT cells are resistant to circulating CD15+ myeloid-derived suppressor cells in patients with head and neck cancer
Atsushi Horinaka et al.
CANCER SCIENCE (2016)
Heme oxygenase-1 regulates mitochondrial quality control in the heart
Travis D. Hull et al.
JCI INSIGHT (2016)
The Akt-mTOR axis is a pivotal regulator of eccentric hypertrophy during volume overload
Masataka Ikeda et al.
SCIENTIFIC REPORTS (2015)
Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
Yoshihiko Ichikawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
-Linolenic acid attenuates doxorubicin-induced cardiotoxicity in rats through suppression of oxidative stress and apoptosis
Xiaohua Yu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2013)
Activation of invariant natural killer T cells by α-galactosylceramide ameliorates myocardial ischemia/reperfusion injury in mice
Tsuneaki Homma et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)
Activation of the p38 MAPK/NF-κB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells
Run-Min Guo et al.
MOLECULAR MEDICINE REPORTS (2013)
Activation of Natural Killer T Cells Ameliorates Postinfarct Cardiac Remodeling and Failure in Mice
Mochamad Ali Sobirin et al.
CIRCULATION RESEARCH (2012)
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Sui Zhang et al.
NATURE MEDICINE (2012)
Doxorubicin and daunorubicin induce processing and release of interleukin-1β through activation of the NLRP3 inflammasome
Kristin A. D. Sauter et al.
CANCER BIOLOGY & THERAPY (2011)
Anti-tumor immune responses induced by iNKT cell-based immunotherapy for lung cancer and head and neck cancer
Shinichiro Motohashi et al.
CLINICAL IMMUNOLOGY (2011)
Metabolic remodeling associated with subchronic doxorubicin cardiomyopathy
Rui A. Carvalho et al.
TOXICOLOGY (2010)
Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk
P. J. Barrett-Lee et al.
ANNALS OF ONCOLOGY (2009)
Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model
Ping Xiang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Mechanisms of NKT cell anergy induction involve Cbl-b-promoted monoubiquitination of CARMA1
Satoshi Kojo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Clinical applications of natural killer T cell-based immunotherapy for cancer
Shinichiro Motohashi et al.
CANCER SCIENCE (2008)
CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system
Jennifer L. Matsuda et al.
CURRENT OPINION IN IMMUNOLOGY (2008)
Toll-like receptor-4 deficiency attenuates doxorubicin-induced cardiomyopathy in mice
Alexander Riad et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
Disruption of nitric oxide synthase 3 protects against the cardiac injury, dysfunction, and mortality induced by doxorubicin
Tomas G. Neilan et al.
CIRCULATION (2007)
Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice
S Matsushima et al.
CIRCULATION (2006)
Natural killer T cell-mediated antitumor immune responses and their clinical applications
Ken-ichiro Seino et al.
CANCER SCIENCE (2006)
Cardiac-specific overexpression of AT1 receptor mutant lacking Gαq/Gαi coupling causes hypertrophy and bradycardia in transgenic mice
PY Zhai et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Involvement of mitogen-activated protein kinases in adriamycin-induced cardiomyopathy
H Lou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Nitric oxide inhibits myocardial apoptosis by preventing caspase-3 activity via S-nitrosylation
Y Maejima et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)
Interferon-γ:: an overview of signals, mechanisms and functions
K Schroder et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Modulation of doxorubicin-induced cardiac dysfunction in Toll-like receptor-2-knockout mice
N Nozaki et al.
CIRCULATION (2004)
Doxorubicin induces early lipid peroxidation associated with changes in glucose transport in cultured cardiomyocytes
S Hrelia et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2002)
Identification of two residues in MCM5 critical for the assembly of minichromosome maintenance complexes and signal transducer and activator of transcription-mediated transcription activation in response to IFN-γ
CJ DaFonseca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen - Role of reactive oxygen and nitrogen species
S Kotamraju et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy.
GM Felker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
